Validation of the Modified Cognitive Assessment Scale (MoCA Blind) for the Diagnosis of Postoperative Neurocognitive Disorders in Patients With Corneal Pathology in Russia.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorThe S.N. Fyodorov Eye Microsurgery State Institution

About this trial

Long-term observation has shown that patients with visual impairment often develop cognitive impairments. Due to the fact that patients who are planning to undergo corneal transplantation may have initial cognitive deficits, assessing cognitive function is an important aspect of work for both the anesthesiologist and the operating surgeon. Given the high significance of assessing cognitive function after anesthesia in ophthalmic surgery patients, it is relevant to adapt and validate the Russian version of the MoCA Blind test for subsequent use in clinical practice.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

patients with corneal pathology, including burns, ulcers, dystrophies, and keratoectasia, as well as those with a history of corneal injuries

physical status of I-III on the ASA scale.

Disqualifiers

children

patients with sensorineural hearing loss

patients with chronic cerebrovascular disorders

patients with initially high levels of anxiety and depressive symptoms

Trial population

Russian-speaking patients with corneal pathology who are planning a corneal transplant in the future

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Neurocognitive testing

    Diagnostic test

    The psychometric properties of the Russian version of the MoCA Blind scale were evaluated according to the following parameters: reliability (reproducibility and internal consistency), validity (content and construct), and sensitivity.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

postoperative neurocognitive disorders

Postoperative neurocognitive disorders were identified by comparing the results of neuropsychological tests performed before surgery and on the 90th day after surgery. An individual Z-score was used for each domain of the test.

Time frame
From the moment of inclusion in the study until the end of treatment 90 days later

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: